Immunodysregulation As an Expression of Underlying Inborn Errors of Immunity: Implementation of Diagnostics and Management of Pediatric and Adult Patients with Immune System Disorders
IRCCS Azienda Ospedaliero-Universitaria di Bologna
400 participants
Sep 15, 2023
OBSERVATIONAL
Conditions
Summary
This is an observational, retro-prospective, moncentric study focused on Inborn Errors of Immunity, an heterogeneous group of inherited diseases due to defects in the differentiation and/or function of the immune system. The primary aim of this study is to obtain a clinical-immunological, functional and molecular characterisation of paediatric and adult patients with confirmed or suspected Inborn Errors of Immunity, particularly of patients with manifestations of immunedysregulation, focusing on clinical course, immunophenotypic laboratory and functional abnormalities, genetic background.
Eligibility
Inclusion Criteria3
- patients with confirmed or suspected Inborn Errors of Immunity;
- age \< 50 years at onset of clinical features suspected for Inborn Errors of Immunity;
- obtaining informed consent from patients or parents/legal guardian of pediatric patients.
Exclusion Criteria1
- • patients in whom infectious susceptibility and immunodysregulation can only be attributed to known non-immunological causes: acquired immunodeficiency secondary to chronic infections (HIV), and acquired immunodeficiency secondary to immunosuppressive treatment.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06773546